Prognostic value of keratin subtyping in transitional cell carcinoma of the upper urinary tract

Virchows Archiv

Volumn 445, Issue 5, 2004, Pages 442-448

  Langner, Cord ^a   Wegscheider, Beate J ^a   Rehak, Peter ^a   Ratschek, Manfred ^a   Zigeuner, Richard ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Immunohistochemistry; Keratin; Prognosis; Transitional cell carcinoma; Upper urinary tract

Indexed keywords

KERATIN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; FEMALE; FISHER EXACT TEST; HUMAN; IMMUNOREACTIVITY; KAPLAN MEIER METHOD; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PHASE TRANSITION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STAINING; STATISTICAL SIGNIFICANCE; TECHNIQUE; URINARY TRACT CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MALE; MIDDLE AGED; PROGNOSIS; UROLOGIC NEOPLASMS;

EID: 9944249666     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-004-1088-z     Document Type: Article

References (39)

1. Alsheikh A, Mohamedali Z, Jones E, Masterson J, Gilks CB (2001) Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behaviour of low-grade papillary urothelial tumors. Mod Pathol 14:267-272
2. Bhatavdekar JM, Patel DD, Chikhlikar PR, Shah NG, Vora HH, Ghosh N, Trivedi TI (2001) Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma. Dis Colon Rectum 44:523-533
3. Bommel van PF, Kenemans P, Helmerhorst TJM, Gallee MPW, Ivanyi D (1994) Expression of cytokeratin 10, 13, and in involucrin as prognostic factors in low stage squamous cell carcinoma of the uterine cervix. Cancer 74:2314-2320
4. Chu PG, Weiss LM (2002) Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases. Mod Pathol 15:6-10
5. Chu PG, Weiss LM (2002) Keratin expression in human tissues and neoplasms. Histopathology 40:403-439
6. Chu PG, Wu E, Weiss LM (2000) Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 13:962-972
7. Chu PG, Lyda MH, Weiss LM (2001) Cytokeratin 14 expression in epithelial neoplasms: a survey of 435 cases with emphasis on its value in differentiating squamous cell carcinomas from other epithelial tumours. Histopathology 39:9-16
8. Cintorino M, Tripod SA, Santopietro R, Antonio P, Lutfi A, Chang F, Syrjanen S, Shen Q, Tosi P, Syrjanen K (2001) Cytokeratin expression patterns as an indicator of tumour progression in oesophageal squamous cell carcinoma. Anticancer Res 21:4195-4201
9. Cohen R, Guber A, Siegal A, Brudermamn I, Huszar M, Yellin A, Marom Z, Geiger B (1997) The prognostic application of cytokeratin typing of nonsmall cell ling carcinoma. A retrospective study. Cancer 79:468-473
10. Depondt J, Shabana AH, Sawaf H, Gehanno P, Forest N (1999) Cytokeratin alterations as diagnostic and prognostic markers of oral and pharyngeal carcinomas. A prospective study. Eur J Oral Sci 107:442-454
11. Genega EM, Porter CR (2002) Urothelial neoplasm of the kidney and ureter. An epidemiologic, pathologic, and clinical review. Am J Clin Pathol 117[Suppl]:S36-S48
12. Guelstein VI, Tchipysheva TA, Ermilova VD, Troyanovsky SM (1993) Immunohistochemical localization of cytokeratin 17 in transitional cell carcinomas of the human urinary tract. Virchows Arch 64:1-5
13. Hall MC, Womack S, Sagalowsky AI (1998) Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52:594-601
14. Harnden P, Parkinson MC (1996) Transitional cell carcinoma of the bladder: diagnosis and prognosis. Curr Diagn Pathol 3:109-121
15. Harnden P, Southgate J (1997) Cytoketain 14 as a marker of squamous differentiation in transitional cell carcinomas. J Clin Pathol 50:1032-1033
16. Harnden P, Allam A, Joyce AD, Patel A, Selby P, Southgate J (1995) Cytokeratin 20 expression by non-invasive transitional cell carcinomas: potential for distinguishing recurrent from non-recurrent disease. Histopathology 27:169-174
17. Harnden P, Mahmood N, Southgate J (1999) Expression of cytokeratin 20 redefines urothelial papillomas of the bladder. Lancet 353:974-977
18. Helpap B, Köllermann J (1999) Proliferative pattern of exophytic and superficially invasive and non-invasive low-grade urothelial carcinomas. Hum Pathol 30:145-150
19. Helpap B, Köllermann J (2000) Assessment of basal cell status and proliferative in flat and papillary urothelial lesions: a contribution to the new WHO classification of urothelial tumors of the bladder. Hum Pathol 31:745-750
20. Helpap B, Schmitz-Dräger BJ, Hamilton PW, Muzzonigro G, Galosi AB, Kurth KH, Lubaroff D, Waters DJ, Droller MJ (2003) Molecular pathology of non-invasive urothelial carcinoma (part I). Virchows Arch 442:309-316
21. Kaufmann O, Fietze E, Mengs J, Dietel M (2001) Value of p63 and cytokeratin 5/6 as immunohsitochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 116:823-830
22. Kim K, Kim S (2002) Immunohistochemical profile of common epithelial neoplasms arising in the kidney. Appl Immunohistochem Mol Morphol 10:332-338
23. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844-847
24. Langner C, Wegscheider BJ, Ratschek M, Schips L, Zigeuner R (2004) Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: a systematic analysis of 233 tumors. Virchows Arch 444:127-134
25. Lopez-Beltran A, Sauter G, Gasser T, Hartmann A, Schmitz-Dräger BJ, Helpap B, Ayala AG, Tamboli P, Knwles MA, Sidransky D, Cordon-Cardo C, Jones PA, Cairns P, Simon R, Amin MB, Tyczynski JE (2004) Tumours of the urinary system. Infiltrating urothelial carcinoma. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) World Health Organization classification of tumours. Pathology and genetics. Tumours of the urinary system and male genital organs. IARC Press, Lyon pp 93-109
26. Miettinen M (1995) Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol 8:384-388
27. Moll R (1998) Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors. Subcell Biochem 31:205-262
28. Moll R, Achtstätter T, Becht E, Balcarova-Ständer J, Ittensohn M, Franke WW (1988) Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinomas and bladder carcinoma cell culture lines. Am J Pathol 132:123-144
29. Moll R, Löwe A, Laufer J, Franke WW (1992) Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 140:427-447
30. Parker DC, Folpe AL, Bell J, Oliva E, Young RH, Cohen C, Amin MB (2003) Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin and cytokeratin 20 in non-invasive, invasive, and metastatic urothelial (transitional cell) carcinomas. Am J Surg Pathol 27:1-10
31. Ramos D, Navarro S, Villamon R, Gil-Salom M, Llombart-Bosch A (2003) Cytokeratin expression patterns in low-grade papillary urothelial neoplasms of the urinary bladder. Cancer 97:1876-1883
32. Rijn van de M, Perou CM, Tibshirani R, Haas P, Kallioniemi O, Kononen J, Torhorst J, Sauter G, Zuber M, Köchli OR, Mross F, Dieterich H, Seitz R, Ross D, Botstein D, Brown P (2002) Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol 161:1991-1996
33. Schaafsma HE, Ramaekers FCS, Muijen van GNP, Lane EB, Leigh IM, Robben H, Huijsmans A, Ooms ECM, Ruiter DJ (1990) Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing patterns during tumour progression. Am J Pathol 136:329-343
34. Schaafsma HE, Ramaekers FCS, Muijen van GNP, Robben H, Lane EB, Leigh IM, Ooms ECM, Schalken JA, Morselaar van RJA, Ruiter DJ (1991) Cytokeratin expression patterns in metastatic transitional cell carcinoma of the urinary tract. An immunohistochemical study comparing local tumor and autologous metastases. Am J Pathol 139:1389-1400
35. Schaller G, Fuchs I, Pritze W, Ebert A, Herbst H, Pantel K, Weitzel H, Lengyel E (1996) Elevated keratin 18 protein expression indicates a favourable prognosis in patients with breast cancer. Clin Cancer Res 2:1879-1885
36. Sobin LH, Wittekind C (eds) (2002) TNM classification of malignant tumors, 6th edn. Wiley-Liss, Inc., New York
37. Southgate J, Harnden P, Trejdosiewicz LK (1999) Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implications. Histol Histopathol 14:657-664
38. Takei H, Iino Y, Horiguchi J, Kanoh T, Takao Y, Oyama T, Morishita Y (1995) Immunohistochemical analysis of cytokeratin 8 as a prognostic factor in invasive breast carcinoma. Anticancer Res 15:1101-1105
39. Wang NP, Zee S, Zarbo RJ, Bacchi CE, Gown AM (1995) Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 3:99-107